Myriad Genetics
MYGN
MYGN
194 hedge funds and large institutions have $1.74B invested in Myriad Genetics in 2023 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 78 increasing their positions, 61 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9.38% more ownership
Funds ownership: 101% → 110.38% (+9.4%)
4% more funds holding
Funds holding: 186 → 194 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
194
Holding in Top 10
1
Calls
$2.81M
Puts
$1.08M
Top Buyers
| 1 | +$28.7M | |
| 2 | +$23.4M | |
| 3 | +$21.4M | |
| 4 |
BlackRock
New York
|
+$19.7M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$19.1M |
Top Sellers
| 1 | -$7.21M | |
| 2 | -$4.66M | |
| 3 | -$4.37M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.75M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$2.21M |